DIH Holdings US, Inc. Class A Common Stock (DHAI)
Official siteMEDICAL DEVICES
Last updated: Nov 11, 2026 at 4:00 PM ET
Earnings
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 69.5% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 64.4, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about DHAI
News
No news available
Company news will appear here when available
DHAI Valuation
- P/FCF
- -0.0x
- P/B
- -0.0x
DHAI Profitability: Margins, ROIC and FCF
- FCF yield
- -818068.9%
DIH Holdings US, Inc. Class A Common Stock Competitors
Peers by sector and size for DIH Holdings US, Inc. Class A Common Stock (DHAI) include STRATA Skin Sciences, Jasper Therapeutics and Genfit.
Sector: Healthcare
DHAI ETF Holders
GNG tracks 1 ETF that holds DHAI.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Feb 21, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About DHAI
Does DHAI pay dividends?
DIH Holdings US, Inc. Class A Common Stock (DHAI) does not currently pay a regular dividend.
DHAI pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.